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Intrinsic involvement of bile ducts, by metastatic
colorectal adenocarcinoma growing from within or
invading the lumen of bile ducts, is not a well
recognized pattern of tumor growth. Clinical, radio-
graphic, operative, and histopathologic aspects of 15
patients with intrabiliary colorectal metastases were
described. Fourteen patients were explored for
possible hepatic resection. Two had jaundice, two
radiographic evidence of an intrabiliary filling
defect, 10 intraoperative evidence of intrabiliary
tumor, and six microscopic evidence of intrabiliary
tumor. Eleven patients underwent hepatic resection.
Five of the resected patients developed hepatic
recurrence. Four patients were explored for possible
repeat resection. One had jaundice, one radiographic
evidence of an intrabiliary filling defect, all had
intraoperative evidence of intrabiliary tumor, and
three microscopic evidence of intrabiliary tumor.
Three patients underwent repeat hepatic resection.
All patients with preoperative jaundice and radio-
graphic evidence of an intrabiliary filling defect
were unresectable. Overall, actuarial five-year sur-
vival is 33% for those patients resected versus 0% for
those not resected. Intraoperative recognition of
intrabiliary tumor at exploration for hepatic resec-
tion was more common than clinical, radiographic,
or histopathologic recognition. More diligent exam-
ination of resected liver tissue by the surgeon and
pathologist may increase identification of bile duct
involvement and aid in achieving adequate tumor
clearance.
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INTRODUCTION
There are approximately 131,000 new cases of
colorectal cancer per year in the United States
[1]. Approximately 50% of these patients will
develop recurrence within five years of treat-
ment of the primary colorectal cancer, with the
liver representing the site of recurrence in 40% to
80% of cases [2-5]. The vast majority of hepatic
colorectal metastases represent parenchymal
lesions. Diffuse parenchymal disease, which is
usually a late finding in patients with extensive
tumor involvement of the liver, is the usual
cause of jaundice [6]. Much less frequently,
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jaundice can be caused solely by involvement
of the bile ducts and, when present, is pre-
dominantly due to extrahepatic extrinsic com-
pression [7-12]. Such extrahepatic obstruction
generally involves metastases to lymph nodes
situated behind the duodenum, along the com-
mon bile duct, or in the porta hepatis. Intrinsic
involvement of the bile ducts, either by meta-
static colorectal adenocarcinoma growing pri-
marily from within intrahepatic or extrahepatic
bile ducts or invading into the lumen of such
ducts, is not a well recognized pattern of spread
of hepatic colorectal metastases and has rarely
been reported in the literature [7, 13-16]. In
the present paper, we report on the clinical,
radiographic, operative, and histopathologic
findings of intrabiliary hepatic colorectal metas-
tases.
PATIENTS AND METHODS
n 15), CT arterial portography (CTAP, n 8),
ultrasound (US, n 11), magnetic resonance
cholangiopancreatography (MRCP, n 5), en-
doscopic retrograde cholangiopancreatography
(ERCP, n 4), and percutaneous transhepatic
cholangiography (PTHC, n 3), were identified.
The original interpreting radiologists’ reports
were reviewed for identification of intrabiliary
filling defects and bile duct dilatation. Reanalysis
of radiographic studies at the time of this analy-
sis was not possible since many studies were
performed at outside hospitals and were not
currently available. The original interpreting
pathologists’ reports were reviewed for evidence
of intrabiliary tumor and then histopathologic
slides were reexamined by a single pathologist
(D.S.K.) at the time of this analysis. Hepatic
resections were classified according to the
Couinaud classification [17,18]. Kaplan-Meier
survival analysis was used to estimate survi-
val time.
Between January, 1991 and January, 1998, 15
cases of intrabiliary hepatic colorectal metastases
were identified by the Hepatobiliary Surgical
Service at Memorial Sloan-Kettering Cancer
Center from approximately 900 patients evalu-
ated with hepatic colorectal metastases. During
this same time period, a total of 430 patients were
operatively explored for hepatic colorectal me-
tastases, of which 313 patients underwent hepa-
tic resection. The cases of intrabiliary hepatic
colorectal metastases were discovered either dur-
ing the preoperative radiographic evaluation,
at operative exploration for attempted hepatic
resection (by gross recognition of intrabiliary
tumor at the time of transection of the bile duct
structures and/or transection of the liver par-
enchyma), at pathologic examination, or at
autopsy. Clinical, radiographic, operative, and
histopathologic findings were examined and con-
trasted for patients at the time of presentation
of initial hepatic metastases and recurrent hepa-
tic metastases. Preoperative radiographic stu-
dies, consisting of computed tomography (CT,
RESULTS
Demographics
Fifteen patients with intrabiliary hepatic color-
ectal metastases were identified between Janu-
ary, 1991 and January, 1998. These patients
consisted of 10 men and 5 women. They had a
median age of 70 years (range 45-80).
Initial Hepatic Colorectal Metastases
The median time interval from resection of
the primary colorectal adenocarcinoma to clini-
cal presentation of hepatic metastases was 31
months (range 0-80). Clinical presentation of
hepatic metastases included the finding of syn-
chronous hepatic metastases in three patients,
jaundice in three patients, and an elevated car-
cinoembryonic antigen (CEA) in 9 patients.
Abnormal laboratory values included an ele-
vated CEA in 14 patients, an elevated serumINTRABILIARY HEPATIC COLORECTAL METASTASES 385
alkaline phosphatase in nine patients, and an
elevated serum total bilirubin in three patients.
Fourteen of 15 patients were explored for
possible hepatic resection. Eleven patients un-
derwent hepatic resection, two underwent
surgical biliary enteric bypass, and one had
placement of an hepatic artery pump. One pa-
tient, presenting with jaundice, was radiogra-
phically determined unresectable secondary to
multiple bilobar hepatic lesions and was found
on both CT and PTHC to have a filling defect
in the distal common bile duct consistent with
intrabiliary tumor. Bile duct cytology showed
malignant cells consistent with adenocar-
cinoma. This patient was not explored and a
percutaneous transhepatic stent was placed.
The clinical, radiographic, operative and
histopathologic evidence of intrabiliary hepatic
colorectal metastases was compared for those 14
patients explored (Tab. I). Two had jaundice
preoperatively, two preoperative radiographic
evidence of an intrabiliary filling defect (Figs. 1
A-C), five preoperative radiographic evidence
of biliary dilatation (Figs. 1B, C), 10 gross evid-
ence of intrabiliary tumor intraoperatively, and
six microscopic evidence of intrabiliary tumor
on initial histopathologic examination. When
histopathology was reexamined at the time
of this analysis, microscopic evidence of intra-
biliary tumor was noted in 10 of 14 patients
explored. One patient explored but not resected
and who did not have gross evidence of intra-
biliary tumor intraoperatively was, 19 months
later at autopsy, found to have gross and micro-
scopic evidence of intrabiliary tumor.
Of 11 patients undergoing hepatic resection
(Tab. I), none had jaundice preoperatively, none
preoperative radiographic evidence of an intra-
biliary filling defect, two preoperative radiogra-
phic evidence of biliary dilatation, eight gross
evidence of intrabiliary tumor intraoperatively,
and four microscopic evidence of intrabiliary
tumor on initial histopathologic examination.
When histopathology was reexamined at the
TABLE Comparison of the clinical, radiographic, operative, and histopathologic evidence of intrabiliary tumor in 15 patients
with initial hepatic colorectal metastases
Radiographic Operative
Case Clinical findings findings findings Operation
Histopathologic findings
(initial exam/reexamination)
jaundice IBT, BDD IBT biliary enteric bypass IBT/IBT
2 none none IBT right hepatectomy none/IBT
3 none BDD IBT left hepatectomy IBT/IBT
4 none BDD IBT right lobectomy none/none
5 none BDD none hepatic artery pump none/none
b
6 none none none right hepatectomy none/IBT
7 none none IBT right hepatectomy IBT/IBT
8 none none IBT segmentectomy (segment 4,5) none/IBT
9 jaundice IBT, BDD N/A N/A IBT/IBT
d
10 none none IBT left hepatectomy IBT/IBT
11 jaundice IBT, BDD IBT biliary enteric bypass IBT/IBT
12 none none none right lobectomy none/none
13 none none none wedge resection none/none
14 none none IBT right lobectomy none/IBT
15 none none IBT right hepatectomy IBT/IBT
BDD bile duct dilation; IBT intrabiliary tumor; N/A--not applicable.
aThis patient had intrabiliary tumor found intraoperately within the bile ducts, did not undergo hepatic resection, and had a
biliary enteric bypass.
bIntrabiliary tumor was found in the bile ducts at autopsy approximately 19 months after placement of hepatic artery pump.
This patient had hepatic disease which was radiographically determined unresectable, did not come to exploration, and had a
erCutaneous transhepatic stent placed.
ytology was positive for adenocarcinoma at percutaneous transhepatic cholangiography.386 S.P. POVOSKI et al.
FIGURES 1A-C Transverse ultrasound image (Fig. 1A) demonstrating a filling defect within the common duct (outlined with
white arrows). Axial computed tomography (CT) image (Fig. 1B) demonstrating intrahepatic biliary dilatation and a filling
defect within the common duct (black arrow). Also note portal lymphadenopathy. Coronal (Fig. 1C) source images from a
magnetic resonance cholangiopancreatography (MRCP) demonstrating biliary dilatation (solid white arrow) and abrupt cutoff
of the common duct (open white arrow) with an intermediate signal intensity filling defect (white asterisk) within the common
duct.INTRABILIARY HEPATIC COLORECTAL METASTASES 387
FIGURES 1A-C (Continued)
time of this analysis, microscopic evidence of radiographically determined at PTHC to have
intrabiliary tumor was noted in eight of 11 high grade obstruction at the confluence of the
patients undergoing hepatic resection, right anterior and posterior sectoral hepatic
ducts which was consistent with intrabiliary
tumor. Bile duct cytology showed malignant Recurrent Hepatic Colorectal Metastases
cells consistent with adenocarcinoma. This
To date, five of 11 patients undergoing hepatic patient was not explored and a percutaneous
resection have developed recurrent hepatic transhepaticstentwas placed.
metastases. The median time interval from The clinical, radiographic, operative and
resection of hepatic metastases to clinical pre- histopathologic evidence of intrabiliary hepatic
sentation of recurrent disease was 23 months colorectal metastases was compared for those 4
(range 22-35). Clinical presentation of recur- patients explored (Tab. II). One had jaundice
rence included jaundice in two patients and preoperatively, one preoperative radiographic
an elevated CEA in three patients. Abnormal evidence of an intrabiliary filling defect and
laboratory values included an elevated CEA in biliary dilatation, all had gross evidence of
four patients, an elevated serum alkaline phos- intrabiliary tumor intraoperatively, and three
phatase in four patients, and an elevated serum microscopic evidence of intrabiliary tumor on
total bilirubin in two patients, initial histopathologic examination. When histo-
Four of five patients were explored for pathology was reexamined at the time of this
possible repeat hepatic resection. Three patients analysis, microscopic evidence of intrabiliary
underwent repeat hepatic resection and one tumor was noted in all four patients explored.
patient underwent surgical biliary enteric by- Of three patients undergoing repeat hepatic
pass. One patient, presenting with jaundice, was resection (Tab. II), none had jaundice preopera-388 S.P. POVOSKI et al.
TABLE II Comparison of the clinical, radiographic, operative, and histopathologic evidence of intrabiliary tumor in five
patients with recurrent hepatic colorectal metastases
Radiographic Operative
Case Clinical findings findings findings Operation
Histopathologic findings
(initial exam/reexamination)
2 jaundice IBT, BDD IBT biliary enteric bypass IBT/IBT
3 jaundice IBT,BDD
b N/A N/A IBT/IBT
6 none none IBT left lobectomy IBT/IBT
12 none none IBT segmentectomy (segment 4) none/IBT
13 none none IBT right lobectomy IBT/IBT
BDD= bile duct dilatation; IBT- intrabiliary tumor; N/A not applicable.
aThis patient had intrabiliary tumor found intraoperately within the bile ducts, did not undergo hepatic resection, and had a
biliary enteric bypass.
bThis patient had hepatic disease which was radiographically determined unresectable, did not come to exploration, and had a
percutaneous transhepatic stent placed.
CCytology was positive for adenocarcinoma at percutaneous transhepatic cholangiography.
tively, none preoperative radiographic evidence
of an intrabiliary filling defect or biliary dilata-
tion, all had gross evidence of intrabiliary tumor
intraoperatively, and two microscopic evidence
of intrabiliary tumor on initial histopathologic
examination. When histopathology was reexa-
mined at the time of this analysis, microscopic
evidence of intrabiliary tumor was noted in
all three patients undergoing repeat hepatic
resection.
Follow-up
Median follow-up for all patients is 19 months
(0-59 months). For those 11 patients under-
going hepatic resection, actuarial five-year sur-
vival is 33% with a median actuarial survival of
52 months (range 0-59). For those four patients
with unresectable hepatic metastases, actuarial
five-year survival is 0% with a median actuarial
survival of 14 months (range 7-19).
DISCUSSION
Intrinsic involvement of the bile ducts either by
metastatic colorectal adenocarcinoma growing
primarily from within intrahepatic or extrahe-
patic bile ducts or invading into the lumen of
such ducts is not a well recognized pattern of
growth of hepatic colorectal metastases and has
rarely been reported in the literature. Two cases
of intrabiliary hepatic colorectal metastases were
first described in the literature by Herbut and
Watson in 1946 [7]. In 1982, Gray et al., described
a case of metastatic colorectal adenocarcinoma
to the liver in which tumor extended into the
lumen of the common bile duct [13]. In 1984,
Roslyn et al., described three cases of metastatic
colorectal adenocarcinoma to the liver in which
intrabiliary tumor debris caused obstruction
at a site distant from the main hepatic tumor
mass and caused intermittent, episodic biliary
obstruction with a clinical picture similar to
choledocholithiasis [14]. Recently, Riopel et al.,
have elegantly outlined the histopathologic
features of eight cases of intrabiliary growth of
hepatic colorectal metastases [16]. They empha-
sized that the intrabiliary growth of hepatic
colorectal metastases along intact basement
membranes of bile ducts may make it difficult
to distinguish metastatic colorectal lesions from
primary bile duct neoplasms.
Recently, Yamamoto et al., specifically exam-
ined the mode of extension of hepatic colorectal
metastases in 40 consecutive patients under-
going hepatic resection at the National Cancer
Center Hospital in Tokyo, Japan [15]. They
reported that 20% of patients (n 8) had gross
bile duct invasion, commonly with papil-
lary growth in the ductal lumen extending
from intraparenchymal metastatic lesions.INTRABILIARY HEPATIC COLORECTAL METASTASES 389
Microscopically, tumor invasion to the bile ducts
was observed in 40% of patients (n 16). These
results would suggest that the phenomenon of
intrabiliary growth and extension of hepatic
colorectal metastases is much more common
than previously thought. There are two potential
reasons why this phenomenon may frequently
go unrecognized. First, since not all patients
with hepatic colorectal metastases undergo
extensive biliary imaging, hepatic resection, or
biliary enteric bypass/stenting, many cases of
intrabiliary involvement may go undetected.
Second, once a patient comes to hepatic resec-
tion, if the pattern of intrabiliary involvement
and spread of hepatic metastases is not specifi-
cally looked for on gross and microscopic
evaluation of resected liver tissue, it may go
unrecognized.
In the present study, we identified 15 cases of
intrabiliary hepatic colorectal metastases. Intra-
operative recognition of intrabiliary tumors at
the time of exploration for possible hepatic
resection was more common than was clinical,
radiographic, or histopathologic recognition.
However, reexamination of the histopathology
at the time of this analysis did confirm all but
one case of intrabiliary tumor identified intra-
operatively. This emphasizes the importance of
the surgeon, at the time of hepatic resection,
carefully examining the resected liver tissue for
gross tumor involvement and extension along or
within the bile ducts. Similarly, this emphasizes
the importance of the pathologist microscopi-
cally examining the resected liver tissue specifi-
cally for bile duct involvement. It is our belief
that recognition of this phenomenon supports a
policy of wide anatomical resection for hepatic
colorectal metastases and should warrant
further resection of involved hepatic parenchy-
ma and bile ducts, if intrabiliary tumor is
identified intraoperatively at the resection mar-
gin. Indeed, this was applicable in our series for
eight patients resected with initial hepatic
metastases and for three patients resected with
recurrent hepatic metastases.
Preoperative jaundice,, as shown in Tables I
and II, was present in three of 15 patients with
initial hepatic metastases and two of five pa-
tients with recurrent hepatic metastases. All
patients with preoperative jaundice had obvious
radiographic evidence of an intrabiliary filling
defect and none of these patients were amend-
able to hepatic resection. Therefore, preoperative
jaundice, although present in only in minority
of patients with intrabiliary tumor, correlates
with preoperative radiographic recognition of
an intrabiliary filling defect as well as the
intraoperative determination of unresectability.
To date, there is no evidence as to the effect
of intrabiliary tumor on the survival of patients
after hepatic resection for hepatic colorectal
metastases. For the 11 patients in our series
undergoing hepatic resection, actuarial five-year
survival is 33%, which is comparable to most
large series evaluating survival after hepatic
resection for hepatic colorectal metastases [19-
25], including our own experience [26]. A cen-
tral question is whether intrabiliary tumor is
responsible for unrecognized tumor involve-
ment of hepatic margins at hepatic resection,
even though the liver parenchymal margin itself
is negative. In the paper by Yamamoto et al.,
they emphasized the importance of recognizing
tumor spread along bile ducts and portal vein
radicals for obtaining complete tumor clearance
[15]. However, they did not evaluate the effect
of finding these factors on postresectional sur-
vival. Likewise, our small cohort of patient does
not allow us to address this issue. This question
would be best addressed in the future by a
prospective clinicopathologic study in which
all resected liver specimens are specifically ex-
amined for ductal and vascular involvement.
While intrabiliary hepatic colOrectal metas-
tases are not a well recognized pattern of growth
of metastatic hepatic colorectal lesions, recent
evidence suggests that this phenomenon is more
common than previously thought. We believe
that more diligent intraoperative gross examina-
tion of resected liver tissue by the surgeon may390 S.P. POVOSKI et al.
increase identification of bile duct involvement.
In turn, this may lead to more appropriate
utilization of intraoperative histopathologic
examination by frozen section to verify such
findings. Taken together, this may aid in
achieving adequate tumor clearance in such
cases. Nevertheless, the impact of finding intra-
biliary hepatic colorectal metastases on survi-
val of patients undergoing hepatic resection
remains uncertain.
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COMMENTARY
The authors have drawn attention to the
involvement of the bile ducts by metastatic
colorectal adenocarcinoma, by reporting 15 cases
from their large experience of 430 patientsINTRABILIARY HEPATIC COLORECTAL METASTASES 391
explored. The cases resected with intrabiliary
tumour represented approximately 4% of their
series of resected patients and is therefore, not
insignificant. They pointed out that with this
report and other recent evidence, the occurr-
ence of bile duct involvement is probably more
common than previously thought.
The question arises regarding the clinical
significance of bile duct involvement. Although
this is a small cohort of their experience, the
survival would appear to be commensurate with
patients who do not have such involvement
and also with reported series of resection for
colorectal liver metastases.
In the jaundiced patients, all had preoperative
radiographic evidence of intrabiliary tumour
and none were amenable to resection. Except
for the non-explored patient who had bilateral
unresectable disease, the reason for non-resect-
ability was not stated. It is uncertain whether
non-resectability was related to intrabiliary
tumour or other reasons. However, it was very
clear that preoperative jaundice due to intrabili-
ary tumour as shown on radiology, correlated
with non-resectability.
The intrabiliary tumour was recognised at
"the time of transection of the bile duct struc-
tures or transection of the liver parenchyma".
This is interpreted as transecting through
tumour at this site, followed by further wider re-
section of the duct/parenchyma to gain clear-
ance. Scheele has reported that re-resection to
gain a clear margin subsequent to identification
of a macroscopic positive margin fails to give
the patient a survival advantage over pat-
ients who had non-curative resection-median
survival of 18 months [1]. Although this does not
refer specifically to bile duct involvement, it
is difficult to perceive the difference. However,
there is a difference with the present series
reporting a median actuarial survival of 52
months.
Obviously, it would be an advantage to avoid
transecting tumour but how can this be
achieved? Evidence of bile duct dilatation on
preoperative imaging or raised biliary enzymes
should alert the surgeon to the possibility of
intrabiliary tumour. This report has highlighted
biliary tract involvement by metastatic colorectal
adenocarcinoma and should prompt surgeons
to identify such by intraoperative ultrasound
and thereby negotiate a wider resection of the
area to avoid transecting the tumour.
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